Drug Database
Back to search

Belgium· BE-AMP-SAM430534-00

Forxiga 10 mg

A dapagliflozin product containing dapagliflozin propanediol monohydrate, registered in Belgium by AstraZeneca. The same ATC class is registered in 16 of our 19 countries.

ATC A10BK01

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedForxiga 10 mgATCA10BK01REGISTER NO.BE-AMP-SAM430534-00PACKS LISTED4CHECKEDSeptember 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about dapagliflozin propanediol monohydrateAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Dapagliflozin is registered in 16 of 19 countries.

Countries holding a registration under ATC A10BK01 (dapagliflozin), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 9 of them publish a price we can compare per daily dose
Search dapagliflozin products by name

Dapagliflozin · ATC A10BK01

16 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of dapagliflozin costs, country by country.

Normalised to the WHO defined daily dose (10 mg), the median price runs from $0.33 in United States to $4.38 in Switzerland — a ×13 gap.

  • 3 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
  • US figures are pharmacy acquisition cost (CMS NADAC), not retail
Open the full comparison — free accountDrug prices for market access

Dapagliflozin · price per daily dose (10 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$4.38
  • IT Italy$3.42
  • US United States$0.33 (acquisition cost)
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Dapagliflozin Propanediol Monohydrate
Manufacturer
AstraZeneca
Country
Belgium (BE)
ATC code
A10BK01
ATC class
Dapagliflozin
Defined daily dose
10 mg, O
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 4

2 priced
  • be_apb
    3018165
    EUR 144.17
  • be_apb
    3018173
    EUR 47.7
  • be_apb
    7716459
  • be_apb
    3034550

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

426 interactions on record for dapagliflozin.

Graded by severity as the source publishes them — 1 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check dapagliflozin against other medicinesHow interaction checks work

Dapagliflozin · interactions on record

426 records

  • 1 severe
  • 378 moderate
  • 47 minor

Most severe, free to view

  • SucralfateA02BX02moderate
  • PapaverineA03AD01moderate
  • ThiethylperazinA04AB03moderate
  • TriflupromazinA04AD06moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Dapagliflozin in 5 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All dapagliflozin products

Authorised across Europe · EMA

The same active substance is authorised in 2 EEA countries. Names it is sold under:

  • Austria · Dapagliflozin Denk
  • Germany · Dapagliflozin Cipla

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f30fe47b-658e-42c6-9835-13db6dc0a4a3
GET /v1/drugs/f30fe47b-658e-42c6-9835-13db6dc0a4a3?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Film-coated tablet",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Forxiga 10 mg",
  "name_fr": "Forxiga 10 mg",
  "name_nl": "Forxiga 10 mg",
  "amp_code": "SAM430534-00",
  "strengths": [
    "10.0000",
    "10.0000",
    "50.0000"
  ],
  "pack_count": 6,
  "substances": [
    "Dapagliflozin Propanediol Monohydrate",
    "Dapagliflozin",
    "Lactose"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Dapagliflozin",
  "authorisation_numbers": [
    "EU/1/12/795/007",
    "EU/1/12/795/006",
    "EU/1/12/795/009",
    "EU/1/12/795/008",
    "EU/1/12/795/010",
    "EU/1/12/795/011"
  ]
}
API referenceMCP serverPlans

See everything about dapagliflozin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console